Aprea Therapeutics (APRE) Institutional Ownership $1.66 +0.06 (+3.75%) Closing price 05/22/2025 03:58 PM EasternExtended Trading$1.68 +0.02 (+0.90%) As of 05/22/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aprea Therapeutics (NASDAQ:APRE)CurrentInstitutional OwnershipPercentage34.19%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$854.84KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$297.77K Get APRE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APRE Institutional Buying and Selling by Quarter Aprea Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Exome Asset Management LLC28,972$59K0.1%-77.4%0.524% 5/14/2025 Stonepine Capital Management LLC102,242$209K0.2%-31.5%1.851% 2/17/2025 Stonepine Capital Management LLC149,221$491K0.4%+8.8%2.748% 2/17/2025 BNP Paribas Financial Markets13,011$43K0.0%N/A0.240% 2/12/2025 Landscape Capital Management L.L.C.35,328$116K0.0%N/A0.651% 2/11/2025 LPL Financial LLC16,052$53K0.0%N/A0.296% 8/21/2024 Stonepine Capital Management LLC137,174$558K0.5%N/A2.526% 8/9/2024 Dimensional Fund Advisors LP11,071$45K0.0%N/A0.204% 5/15/2023 AIGH Capital Management LLC345,000$1.53M0.6%N/A9.244% 5/15/2023 Sio Capital Management LLC280,000$1.24M0.6%N/A7.503% Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2022Gyon Technologies Capital Management LP20,570$38K0.0%N/A0.094% 5/12/2022 Magnus Financial Group LLC14,856$28K0.0%-56.3%0.068% 2/15/2022 Kennedy Capital Management Inc.336,730$966K0.0%-1.7%1.569% 2/14/2022 PDT Partners LLC142,600$409K0.0%+62.5%0.664% 2/10/2022 Magnus Financial Group LLC33,981$98K0.0%N/A0.158% 11/16/2021 Verition Fund Management LLC20,101$103K0.0%N/A0.094% 11/12/2021 Geode Capital Management LLC198,339$1.01M0.0%+89.9%0.936% 11/10/2021 Goldman Sachs Group Inc.144,758$740K0.0%+131.4%0.683% 11/9/2021BlackRock Inc.354,275$1.81M0.0%-0.9%1.672% 9/17/2021 Virtu Financial LLC41,142$201K0.0%+292.9%0.194% 8/17/2021 Walleye Capital LLC98,931$483K0.0%-16.5%0.467% 8/17/2021 Walleye Trading LLC27,455$134K0.0%-33.4%0.130% 8/16/2021 PDT Partners LLC124,234$606K0.0%N/A0.586% 8/16/2021 Morgan Stanley1,019,776$4.98M0.0%+2.2%4.813% 8/16/2021 Kennedy Capital Management Inc.353,926$1.73M0.0%+575.2%1.670% 8/16/2021 Charles Schwab Investment Management Inc.50,366$246K0.0%-26.5%0.238% 8/16/2021 State Street Corp40,832$199K0.0%-67.2%0.193% 8/16/2021 Goldman Sachs Group Inc.62,546$305K0.0%-14.4%0.295% 8/13/2021 Northern Trust Corp32,530$159K0.0%-69.2%0.154% 8/13/2021 Geode Capital Management LLC104,447$509K0.0%-35.2%0.493% 8/13/2021 Vanguard Group Inc.707,422$3.45M0.0%-6.0%3.339% 8/12/2021 SG Americas Securities LLC598,395$2.92M0.0%-8.8%2.824% 8/12/2021 JPMorgan Chase & Co.60,315$294K0.0%+264.4%0.285% 8/12/2021Ergoteles LLC18,570$91K0.0%N/A0.088% 8/11/2021 Great Lakes Advisors LLC17,895$87K0.0%N/A0.084% 8/11/2021 Bank of New York Mellon Corp16,843$83K0.0%-64.8%0.079% 5/19/2021 Virtu Financial LLC10,471$53K0.0%-56.4%0.049% 5/18/2021 Voloridge Investment Management LLC304,198$1.55M0.0%N/A1.436% 5/18/2021 Morgan Stanley998,127$5.09M0.0%+111.0%4.711% 5/18/2021 Redmile Group LLC694,918$3.54M0.0%-45.2%3.280% Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now.5/17/2021 Royal Bank of Canada15,173$76K0.0%+76.5%0.072% 5/17/2021 Walleye Trading LLC41,254$210K0.0%+7.4%0.195% 5/17/2021 Walleye Capital LLC118,476$604K0.0%+17.5%0.559% 5/17/2021 HRT Financial LP73,587$375K0.0%N/A0.347% 5/17/2021Nuveen Asset Management LLC17,565$90K0.0%-48.7%0.083% 5/17/2021 5AM Venture Management LLC619,157$3.16M0.6%-55.1%2.922% 5/17/2021 Goldman Sachs Group Inc.73,107$373K0.0%N/A0.345% 5/14/2021 Kennedy Capital Management Inc.52,415$267K0.0%N/A0.247% 5/14/2021 FIL Ltd83,191$424K0.0%+17,267.6%0.393% 5/14/2021 UBS Asset Management Americas Inc.22,700$116K0.0%N/A0.107% 5/13/2021 Trexquant Investment LP25,361$129K0.0%N/A0.120% 5/13/2021 SG Americas Securities LLC655,888$3.35M0.0%+2,725.9%3.096% 5/13/2021 Bank of New York Mellon Corp47,783$244K0.0%+57.5%0.226% 5/12/2021 Northern Trust Corp105,719$539K0.0%-6.8%0.499% 5/12/2021 Geode Capital Management LLC161,147$821K0.0%+9.1%0.761% 5/12/2021 JPMorgan Chase & Co.16,550$85K0.0%+380.3%0.078% 5/7/2021BlackRock Inc.810,852$4.14M0.0%-2.1%3.827% 5/3/2021 Zurcher Kantonalbank Zurich Cantonalbank8,254$42K0.0%N/A0.039% (Data available from 1/1/2016 forward) APRE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APRE shares? During the previous two years, the following institutional investors and hedge funds held shares of Aprea Therapeutics shares: Stonepine Capital Management LLC ($209K), Landscape Capital Management L.L.C. ($116K), Exome Asset Management LLC ($59K), LPL Financial LLC ($53K), and Dimensional Fund Advisors LP ($45K), BNP Paribas Financial Markets ($43K).Learn more on APRE's institutional investors. What percentage of Aprea Therapeutics stock is owned by institutional investors? 34.19% of Aprea Therapeutics stock is owned by institutional investors. Learn more on APRE's institutional investor holdings. Which institutional investors have been buying Aprea Therapeutics stock? The following institutional investors have purchased Aprea Therapeutics stock in the last 24 months: Stonepine Capital Management LLC ($149.22K), Landscape Capital Management L.L.C. ($35.33K), LPL Financial LLC ($16.05K), BNP Paribas Financial Markets ($13.01K), and Dimensional Fund Advisors LP ($11.07K). How much institutional buying is happening at Aprea Therapeutics? Institutional investors have bought a total of 224,683 shares in the last 24 months. This purchase volume represents approximately $854.84K in transactions. Which Aprea Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Aprea Therapeutics stock in the last 24 months: Exome Asset Management LLC ($98.99K), and Stonepine Capital Management LLC ($46.98K). How much institutional selling is happening at Aprea Therapeutics? Institutional investors have sold a total of 145,967 shares in the last 24 months. This volume of shares sold represents approximately $297.77K in transactions. Related Companies SPRO Institutional Ownership LVTX Institutional Ownership FBLG Institutional Ownership DYAI Institutional Ownership BLUE Institutional Ownership KZR Institutional Ownership FGEN Institutional Ownership MRNS Institutional Ownership INKT Institutional Ownership ALLK Institutional Ownership This page (NASDAQ:APRE) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APRE Stock Free APRE Stock Alerts